Patient-reported outcomes in chronic gout: A report from OMERACT 10

Journal of Rheumatology

Volumn 38, Issue 7, 2011, Pages 1452-1457

  Singh, Jasvinder A ^a,b,c   Taylor, Will J ^d   Simon, Lee S ^e   Khanna, Puja P ^f   Stamp, Lisa K ^g   McQueen, Fiona M ^h   Neogi, Tuhina ⁱ   Gaffo, Angelo L ^a   Becker, Michael A ^j   MacDonald, Patricia A ^k   Dabbous, Omar ^l   Strand, Vibeke ^m   Dalbeth, Nicola D ^h   Aletaha, Daniel ⁿ   Edwards, N Lawrence ^o   Schumacher Jr , H Ralph ^p  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e SDG LLC   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF OTAGO   (New Zealand)

^h UNIVERSITY OF AUCKLAND   (New Zealand)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k TAKEDA PHARMACEUTICALS   (United States)

^l Takeda Pharmaceuticals International Inc   (United States)

^m STANFORD UNIVERSITY   (United States)

ⁿ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^o UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Chronic gout; Functional limitation; Pain; Patient global; Patient reported outcomes; Validation

Indexed keywords

FEBUXOSTAT; PEGLOTICASE;

CONFERENCE PAPER; DAILY LIFE ACTIVITY; DISEASE SEVERITY; GOUT; GOUT ASSESSMENT QUESTIONNAIRE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERNAL CONSISTENCY; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; VALIDATION PROCESS; VISUAL ANALOG SCALE; WORKSHOP; CHRONIC DISEASE; CHRONIC PAIN; FEASIBILITY STUDY; JOINT LIMITATION; PAIN THRESHOLD; PATIENT ATTITUDE; QUESTIONNAIRE; RATING SCALE; REVIEW; SELF REPORT; SHORT FORM 36;

CHRONIC DISEASE; DISABILITY EVALUATION; FEASIBILITY STUDIES; GOUT; GOUT SUPPRESSANTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT; TREATMENT OUTCOME;

EID: 79959987441     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110271     Document Type: Conference Paper

References (22)

1. U.S. Department of Health and Human Services. Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to support labeling claims. [Internet. Accessed 15 March 2011.] Rockville, Maryland; 2009. Available from: http://www.fda.gov/ downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM193282.pdf
2. NIH. PROMIS. Patient-Reported Outcomes Measurement Information System: dynamic tools to measure health outcomes from the patient perspective. [Internet. Accessed March 15, 2011.]. National Institutes of Health. Available from: http://www.nihpromis.org/default.aspx.
3. Halpern R, Fuldeore MJ, Mody RR, Patel PA, Mikuls TR. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol 2009;15:3-7.
4. Kleinman NL, Brook RA, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, et al. The impact of gout on work absence and productivity. Value Health 2007;10:231-7. (Pubitemid 47077244)
5. Krishnan E. Gout and coronary artery disease: epidemiologic clues. Curr Rheumatol Rep 2008;10:249-55.
6. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96.
7. Singh JA. Quality of life and quality of care for patients with gout. Curr Rheumatol Rep 2009;11:154-60.
8. Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008;67:1310-6.
9. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008;168:1104-10. (Pubitemid 351749228)
10. Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36:2342-5.
11. Taylor WJ, Schumacher HR Jr, Singh JA, Grainger R, Dalbeth N. Assessment of outcome in clinical trials of gout: a review of current measures. Rheumatology 2007;46:1751-6. (Pubitemid 350168287)
12. Sundy JS, Baraf HSB, Becker MA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, et al. Efficacy and safety of intravenous pegloticase (pgl) in treatment failure gout (TFG): Results from GOUT1 And GOUT2 [abstract]. Ann Rheum Dis 2009;68 Suppl 3:318.
13. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-61. (Pubitemid 41781828)
14. Schumacher HR Jr, Becker MA, Wortmann RL, MacDonald PA, Hunt B, Streit J, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum 2008;59:1540-8.
15. Katz S, Ford A, Moskowitz R, Jackson B, Jaffe M. Studies of illness in aged: The index of ADL: A standard measure of biological and psychological function. JAMA 1963;185:914-9.
16. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45. (Pubitemid 10164318)
17. van Groen MM, Ten Klooster PM, Taal E, van de Laar MA, Glas CA. Application of the Health Assessment Questionnaire Disability Index to various rheumatic diseases. Qual Life Res 2010;19:1255-63.
18. Alvarez-Hernandez E, Pelaez-Ballestas I, Vazquez-Mellado J, Teran-Estrada L, Bernard-Medina AG, Espinoza J, et al. Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum 2008;59:665-9. (Pubitemid 351679541)
19. Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N. The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol 2008;26:620-6.
20. Colwell HH, Hunt BJ, Pasta DJ, Palo WA, Mathias SD, Joseph-Ridge N. Gout Assessment Questionnaire: Initial results of reliability, validity and responsiveness. Int J Clin Pract 2006;60:1210-7.
21. Hirsch JD, Lee SJ, Terkeltaub R, Khanna D, Singh J, Sarkin A, et al. Evaluation of an instrument assessing influence of gout on health-related quality of life. J Rheumatol 2008;35:2406-14.
22. Khanna D, Sarkin AJ, Khanna PP, Shieh MM, Kavanaugh AF, Terkeltaub RA, et al. Responsiveness to change and minimally important differences of the gout impact scale in a randomized controlled trial 2010. Rheumatology 2011 Mar 3. [Epub ahead of print]